Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol.

The 1996 American Heart Association consensus panel recommendations stated that pre-participation cardiovascular screening for young competitive athletes is justifiable and compelling on ethical, legal, and medical grounds. The present article represents the consensus statement of the Study Group on Sports Cardiology of the Working Group on Cardiac Rehabilitation and Exercise Physiology and the Working Group on Myocardial and Pericardial diseases of the European Society of Cardiology, which comprises cardiovascular specialists and other physicians from different European countries with extensive clinical experience with young competitive athletes, as well as with pathological substrates of sudden death. The document takes note of the 25-year Italian experience on systematic pre-participation screening of competitive athletes and focuses on relevant issues, mostly regarding the relative risk, causes, and prevalence of sudden death in athletes; the efficacy, feasibility, and cost-effectiveness of population-based pre-participation cardiovascular screening; the key role of 12-lead ECG for identification of cardiovascular diseases such as cardiomyopathies and channelopathies at risk of sudden death during sports; and the potential of preventing fatal events. The main purpose of the consensus document is to reinforce the principle of the need for pre-participation medical clearance of all young athletes involved in organized sports programmes, on the basis of (i) the proven efficacy of systematic screening by 12-lead ECG (in addition to history and physical examination) to identify hypertrophic cardiomyopathy—the leading cause of sports-related sudden death—and to prevent athletic field fatalities; (ii) the potential screening ability in detecting other lethal cardiovascular diseases presenting with ECG abnormalities. The consensus document recommends the implementation of a common European screening protocol essentially based on 12-lead ECG.

[1]  H. Friedman.  Diagnostic electrocardiography and vectorcardiography , 1971 .

[2]  Diagnostic Electrocardiography and Vectocardiography. , 1972 .

[3]  W. Roberts,et al.  Sudden Death in Young Athletes , 1980, Circulation.

[4]  R Frank,et al.  Right Ventricular Dysplasia: A Report of 24 Adult Cases , 1982, Circulation.

[5]  J. Mitchell,et al.  16th Bethesda Conference: Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. October 3-5, 1984. , 1985, Journal of the American College of Cardiology.

[6]  B. Maron,et al.  Results of screening a large group of intercollegiate competitive athletes for cardiovascular disease. , 1987, Journal of the American College of Cardiology.

[7]  D. Corrado,et al.  Right ventricular cardiomyopathy and sudden death in young people. , 1988, The New England journal of medicine.

[8]  D. Corrado,et al.  Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. , 1990, The American journal of medicine.

[9]  J E Smialek,et al.  Sports-related and non-sports-related sudden cardiac death in young adults. , 1991, American heart journal.

[10]  D. Corrado,et al.  Non-atherosclerotic coronary artery disease and sudden death in the young , 1992, British heart journal.

[11]  B. Maron,et al.  26th Bethesda Conferance: Recommendations for determining eligibility for competetion in athletes with cardiovascular abnormalities , 1994 .

[12]  A. Angelini,et al.  Sudden death in the young. Is acute coronary thrombosis the major precipitating factor? , 1994, Circulation.

[13]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[14]  B. Maron,et al.  Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience. , 1995, The American journal of cardiology.

[15]  R. Cantu,et al.  Nontraumatic sports death in high school and college athletes. , 1995, Medicine and science in sports and exercise.

[16]  F O Mueller,et al.  Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. , 1996, JAMA.

[17]  D. Atkins,et al.  Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. , 1996, Circulation.

[18]  G. R. Paul,et al.  The preparticipation sports examination for high school and college athletes. , 1997, Clinics in sports medicine.

[19]  D. Corrado,et al.  Screening for hypertrophic cardiomyopathy in young athletes. , 1998, The New England journal of medicine.

[20]  B. Maron,et al.  Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. , 1998, Journal of the American College of Cardiology.

[21]  B. Maron,et al.  Profile of preparticipation cardiovascular screening for high school athletes. , 1998, JAMA.

[22]  D. Corrado,et al.  CARDIOMYOPATHY Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment , 2022 .

[23]  G. Danieli,et al.  Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. , 2000, Journal of the American College of Cardiology.

[24]  B. Maron,et al.  Preparticipation cardiovascular screening for US collegiate student-athletes. , 2000, JAMA.

[25]  D. Corrado,et al.  Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. , 2000, Journal of the American College of Cardiology.

[26]  B. Maron.  Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[27]  A. Matsumori,et al.  Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey , 2002, Heart.

[28]  B. Maron.  Sudden death in young athletes. , 1980, The New England journal of medicine.

[29]  H. Heidbuchel,et al.  High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification. , 2003, European heart journal.

[30]  F. Marcus,et al.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2000, Circulation.

[31]  Maurizio Schiavon,et al.  Does sports activity enhance the risk of sudden death in adolescents and young adults? , 2003, Journal of the American College of Cardiology.

[32]  M. Law.  Screening without evidence of efficacy , 2004, BMJ : British Medical Journal.

[33]  Michael J Ackerman,et al.  Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. , 2004, Circulation.

[34]  B. Maron.  How should we screen competitive athletes for cardiovascular disease? , 2005, European heart journal.

[35]  C. Wren,et al.  Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. , 2005, European heart journal.

[36]  Maurizio Schiavon,et al.  Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. , 2006, JAMA.

[37]  Barry J Maron,et al.  Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. , 2006, European heart journal.

[38]  Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy: Identification with the Italian Preparticipation Athlete Screening Program , 2007 .